Market Share of Global Minimal Residual Disease Industry
The minimal residual disease market is highly competitive and consists of several major players. The companies are investing in research and development activities to provide patients with better treatment and detection methods and adopt various business strategies such as collaboration and acquisitions to withhold their positions in the market. Some key players are Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, and Amgen Inc.
Minimal Residual Disease Market Leaders
-
Adaptive Biotechnologies
-
Bristol-Myers Squibb Company
-
Kite Pharma
-
Natera
-
Amgen Inc.
*Disclaimer: Major Players sorted in no particular order
